Growth Metrics

Plus Therapeutics (PSTV) Interest Coverage Ratio (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Interest Coverage Ratio for 15 consecutive years, with 6.45 as the latest value for Q1 2025.

  • Quarterly Interest Coverage Ratio rose 93.35% to 6.45 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was 27.92 through Dec 2025, up 66.0% year-over-year, with the annual reading at 27.92 for FY2025, 66.0% up from the prior year.
  • Interest Coverage Ratio for Q1 2025 was 6.45 at Plus Therapeutics, up from 68.42 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 6.45 in Q1 2025, with the low at 136.93 in Q2 2024.
  • Average Interest Coverage Ratio over 5 years is 43.03, with a median of 31.48 recorded in 2022.
  • The sharpest move saw Interest Coverage Ratio crashed 929.24% in 2024, then surged 93.35% in 2025.
  • Over 5 years, Interest Coverage Ratio stood at 15.08 in 2021, then plummeted by 232.84% to 50.2 in 2022, then dropped by 23.96% to 62.23 in 2023, then decreased by 9.96% to 68.42 in 2024, then surged by 90.57% to 6.45 in 2025.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 6.45, 68.42, and 62.28 for Q1 2025, Q4 2024, and Q3 2024 respectively.